Brief: Sigilon Therapeutics Reports Q4 And Full Year 2022 Financial Results And Business Highlights
14/03/2023 22:55
March 14 (Reuters) - Sigilon Therapeutics Inc SGTX.O :
* SIGILON THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
* EXTENDED ANTICIPATED CASH RUNWAY INTO 2025
* QTRLY LOSS PER SHARE $0.21
* Q4 EARNINGS PER SHARE VIEW $-0.38 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXbMxBWK
Further company coverage: SGTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sigilon Therapeutics
See all newsSigilon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Sigilon Therapeutics Inc expected to post a loss of $4.71 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Micron, Greenbrier, Immunome
Sigilon jumps on Eli Lilly's buyout deal to expand diabetes treatments
U.S. STOCKS ON THE MOVE-Sigilon, Netflix, RenovoRx